Bengaluru-based microbiome health startup plans to scale IP, tech, and team
Seed Round Led by IPV
Deep-science startup Iom Bioworks, focused on personalized gut microbiome healthcare, has raised ₹4 crore in its seed funding round, led by Inflection Point Ventures (IPV). The funding round aims to bolster the company’s research, marketing, infrastructure, and hiring initiatives.
Inflection Point Ventures, one of India’s most active angel investment platforms, continues to support early-stage ventures with deep tech and health-tech potential. The company now joins the growing portfolio of scientific health startups backed by IPV.
About Iom Bioworks
Founded in 2022, Iom Bioworks is the brainchild of Bipin Pradeep Kumar (CEO), Dr. Samik Ghosh (Chief of Science & Technology), and Dr. Hiroaki Kitano, a globally renowned systems biologist and AI expert. The startup’s mission is to revolutionize healthcare by personalizing wellness strategies based on an individual’s gut microbiome composition.
The platform employs AI-driven biological network mapping, nutritional science, and microbiology to create individualized food and prebiotic plans aimed at improving digestion, immunity, metabolism, and mental health.
Services and Early Traction
The company operates a pan-India, digital-first model, allowing users to order at-home gut profiling kits, submit samples, and receive data-driven health recommendations online.
In its first year of operation:
- It has served over 500 customers across major Indian cities.
- Secured two patents, with two more under review.
- Published peer-reviewed research in reputed journals (specific studies remain undisclosed due to ongoing IP processes).
- Built a logistics and diagnostics network enabling rapid sample processing and delivery.
Users receive insights on their gut microbiota along with dietary and lifestyle advice tailored to their individual health profiles.
Use of Funds
The ₹4 crore raised in this round will be deployed across four primary areas:
- Marketing and Consumer Education – To build awareness around microbiome health and Iom’s offering.
- Intellectual Property Protection – For patenting its AI models and gut microbiome mapping technology.
- Infrastructure Expansion – To scale its in-house laboratories and digital tech platforms.
- Hiring Scientific and Commercial Talent – To grow its multidisciplinary team of biologists, engineers, and wellness advisors.
Also Read: Kisah Apparels Raises ₹13 Crore in Pre-Series A Round to Fuel Omnichannel Expansion
Statements from Stakeholders
Vinay Bansal, Founder & CEO of Inflection Point Ventures, emphasized the importance of microbiome health in modern wellness:
“With lifestyle diseases on the rise, understanding and nurturing the gut microbiome offers a powerful preventive approach. The company is translating high science into consumer wellness in a way that is both actionable and scalable.”
Bipin Pradeep Kumar, Co-founder and CEO of Iom Bioworks, said:
“Our goal is to empower individuals to optimize their health through personalized interventions based on their gut bacteria. This funding will help us deepen our R&D and bring these solutions to more people across India.”
A Growing Market Opportunity
According to Grand View Research, the global human microbiome market is expected to reach USD 1.37 billion by 2030, growing at a CAGR of 28.2%. In India, consumer awareness about gut-brain health, immunity, and personalized diets is accelerating, especially post-COVID.
Startups like Iom Bioworks are uniquely positioned to bridge the gap between cutting-edge biological research and real-world health applications.
Future Plans
With the new funding, The company plans to:
- Accelerate R&D in food-microbiome interaction.
- Expand IP filings to international markets.
- Enhance data analytics infrastructure.
- Onboard senior scientific leadership and business development experts.
The company also aims to explore partnerships with wellness brands, nutraceutical companies, and digital health platforms to broaden its ecosystem.
Why It Matters
The company represents a new wave of healthcare innovation in India, where data, AI, and biology converge to create deeply personalized health interventions. With increasing consumer interest in longevity, immunity, and mental wellness, the startup’s science-led, user-friendly model could play a pivotal role in the next frontier of preventive healthcare.
In conclusion,The company has successfully combined scientific expertise, digital convenience, and consumer relevance to build a promising healthtech venture. With IPV’s backing and a clear roadmap ahead, the startup is poised to advance India’s role in the global microbiome revolution.
Also Read: How to Start a Candle-Making Business at Home in India
